Recent progress of aptamer‒drug conjugates in cancer therapy

Aptamers are single-stranded DNA or RNA sequences that can specifically bind with the target protein or molecule via specific secondary structures. Compared to antibody-drug conjugates (ADC), aptamer‒drug conjugate (ApDC) is also an efficient, targeted drug for cancer therapy with a smaller size, higher chemical stability, lower immunogenicity, faster tissue penetration, and facile engineering. Despite all these advantages, several key factors have delayed the clinical translation of ApDC, such as in vivo off-target effects and potential safety issues. In this review, we highlight the most recent progress in the development of ApDC and discuss solutions to the problems noted above.

Study on PSA oxygen generating technology with variable frequencies,constant pressure and self-adaptivity to altitude changes / 医疗卫生装备

Objective To provide technical support for developing portable and carrying PSA medical oxygen generators under variable altitudes. Methods Based on the operation principle of PSA technology, the effects of altitude on the performance capacity of series of PSA medical oxygen generators were analyzed. PSA oxygen generating technology was explored with an inlet system with variable frequencies and constant pressure. The problems due to the introduction of the converter were discussed during studying key technologies, and some countermeasures were put forward accordingly. Trials were executed with 1.2 Nm3/h generator taken as an example. Results The PSA medical oxygen generator developed met the requirements of corresponding standards of medical molecular sieve oxygen generator at the altitudes from 0 to 4451 m. Conclusion The PSA oxygen generator has its adaption altitude enhanced significantly.